Ziyou Cui
Eureka Therapeutics (United States)(US)
Publications by Year
Research Areas
Muscle Physiology and Disorders, Ubiquitin and proteasome pathways, Cardiomyopathy and Myosin Studies, CAR-T cell therapy research, Advanced Proteomics Techniques and Applications
Most-Cited Works
- → DUX4 recruits p300/CBP through its C-terminus and induces global H3K27 acetylation changes(2016)216 cited
- → Regulation of cardiac proteasomes by ubiquitination, SUMOylation, and beyond(2013)89 cited
- → Proteomic analysis of mitochondria from Caenorhabditis elegans(2009)67 cited
- → A novel P300 inhibitor reverses DUX4-mediated global histone H3 hyperacetylation, target gene expression, and cell death(2019)67 cited
- → Identification of the Immunoproteasome as a Novel Regulator of Skeletal Muscle Differentiation(2013)66 cited
- → Discovery and identification of potential biomarkers of pediatric Acute Lymphoblastic Leukemia(2009)55 cited
- → Preliminary quantitative profile of differential protein expression between rat L6 myoblasts and myotubes by stable isotope labeling with amino acids in cell culture(2009)52 cited
- → Loss of FHL1 induces an age-dependent skeletal muscle myopathy associated with myofibrillar and intermyofibrillar disorganization in mice(2013)47 cited
- → Overexpression of Cell Surface Cytokeratin 8 in Multidrug-Resistant MCF-7/MX Cells Enhances Cell Adhesion to the Extracellular Matrix(2008)46 cited
- → Different effects of the nonsteroidal anti-inflammatory drugs meclofenamate sodium and naproxen sodium on proteasome activity in cardiac cells(2016)41 cited